Silver Spring, MD, United States of America

Lyle David Isaacs

This inventor holds 8 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignees: University System of Maryland, The General Hospital Corporation, Pohang University of Science and Technology Foundation. Active years: 2008-2024.

USPTO Granted Patents = 8 (Patent Applications = 5)

% Patents Active = 62.5

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 16(Granted Patents)

Location History:

Beltsville, MD (US) (2012)
Bethesda, MD (US) (2008 - 2013)
Silver Spring, MD (US) (2016 - 2024)

Company Filing History:

8 out of 2,025

University System of Maryland

patents

2 out of 3,071

The General Hospital Corporation

patents

1 out of 1,101

Pohang University of Science and Technology Foundation

patents

where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11897893 - Molecular containers and methods of making and using same (2024-02-13),

2. 9956229 - Acyclic cucurbit[n]uril type molecular containers to treat intoxication and decrease relapse rate in substance abuse disorders (2018-05-01),

3. 9567344 - Molecular containers and methods of making and using same (2017-02-14),

4. 9566351 - Molecular containers and methods of making and using same (2017-02-14),

5. 9469648 - Reversal of drug-induced neuromuscular block using novel molecular containers (2016-10-18),

6. 8513409 - Introverted CB[n] compounds (2013-08-20),

7. 8299269 - Nor-seco-bis-nor-seco, tris-nor-seco, and higher nor-seco-cucurbit[n]uril compounds (2012-10-30),

8. 7335768 - Cucurbit [n] uril compounds and analogs, and methods of making and using the same (2008-02-26),

Title: **Lyle David Isaacs: Innovating Molecular Solutions**

Introduction

Lyle David Isaacs, based in Silver Spring, MD, is an accomplished inventor with a remarkable portfolio of 8 patents. His innovative work primarily focuses on the development of molecular containers and therapeutic methodologies that address pressing medical needs.

Latest Patents

Among his latest innovations are groundbreaking patents concerning acyclic CB[n]-type compounds. These compounds serve as molecular containers capable of solubilizing pharmaceutical agents, thus enhancing their effectiveness. Notably, these innovations also contribute to a range of therapeutic applications aimed at preventing and treating various medical conditions. Another significant patent elaborates on methods to reverse the effects of drug intoxication. This method utilizes acyclic CB[n]-type compounds to aid individuals suffering from the consequences of substance abuse, thereby promoting recovery and reducing relapse rates.

Career Highlights

Throughout his career, Lyle David Isaacs has contributed substantially to the field of molecular chemistry. His tenure at the University System of Maryland and The General Hospital Corporation has positioned him at the forefront of research and development in therapeutic innovations, enabling advances that have the potential to transform patient care.

Collaborations

Isaacs has collaborated with notable colleagues, including Volker Briken and Gaya Hettiarachchi, further enriching the scope and impact of his work. These partnerships have been instrumental in the progression of innovative solutions aimed at improving health outcomes.

Conclusion

Lyle David Isaacs represents a significant force in the arena of molecular inventions and therapeutic approaches. His patents not only exemplify cutting-edge research but also demonstrate a dedicated commitment to enhancing public health through innovative solutions. As he continues to push the boundaries of science, Lyle David Isaacs remains an inspiring figure in the realm of invention and innovation.